Acquisition (code M) of 29,849 shares at $0 per share.
Reporting Person Khattar Jack A. · Officer Title President, CEO · Transaction Code M
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001539937-26-000012 · filed 2026-08-14 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "SUPERNUS PHARMACEUTICALS, INC. (SUPN)." Disclosed 2026-08-14. https://desqlong.com/cards/0001539937-26-000012-1 (retrieved 2026-09-26).